A phase 1 study of MSC-1, a humanized anti-LIF monoclonal antibody, in patients with advanced solid tumors.

被引：4
|
作者：
Hyman, David Michael
Brana, Irene
Spreafico, Anna
Schram, Alison M.
Pandya, Naimish B.
Hoffman, Kimberly
Hallet, Robin
Giblin, Patricia
Anido, Judit
Ruano, Isabel Huber
Wasserman, Robert
Magram, Jeanne
Siu, Lillian L.
Tabernero, Josep
Seoane, Joan
Baselga, Jose
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] UHN Princess Margaret Hosp, Cambridge, ON, Canada
[3] Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[5] Northern Biol Inc, Toronto, ON, Canada
[6] Vall dHebron Univ Hosp, Barcelona, Spain
[7] Vall dHebron Inst Oncol VHIO, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.TPS2602
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2602
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A PHASE 1 STUDY OF SERPLULIMAB (A NOVEL ANTI-PD-1 ANTIBODY) IN COMBINATION WITH HLX04 (AN ANTI-VEGF ANTIBODY) IN PATIENTS WITH ADVANCED SOLID TUMORS.
    Guo, Y.
    Li, J.
    Li, Q.
    Xue, J.
    Xue, L.
    Ge, X.
    Lin, F.
    Zhao, W.
    Tang, W.
    Peng, D.
    Wang, Q.
    Zhu, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S29 - S30
  • [22] A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors
    Sasaki, Yasutsuna
    Miwa, Keisuke
    Yamashita, Keishi
    Sunakawa, Yu
    Shimada, Ken
    Ishida, Hiroo
    Hasegawa, Kosei
    Fujiwara, Keiichi
    Kodaira, Makoto
    Fujiwara, Yasuhiro
    Namiki, Masayuki
    Matsuda, Minami
    Takeuchi, Yutaka
    Katsumata, Noriyuki
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (02) : 332 - 340
  • [23] Phase I study of MK-3475 (anti-PD-1 monoclonal antibody) in patients with advanced solid tumors
    Patnaik, Amita
    Kang, Soonmo Peter
    Tolcher, Anthony W.
    Rasco, Drew Warren
    Papadopoulos, Kyriakos P.
    Beeram, Muralidhar
    Drengler, Ronald
    Chen, Cong
    Smith, Lon
    Perez, Crystal
    Gergich, Kevin
    Lehnert, Manfred
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Pharmacokinetics of MEDI4736, a fully human anti-PDL1 monoclonal antibody, in patients with advanced solid tumors.
    Fairman, David
    Narwal, Rajesh
    Liang, Meins
    Robbins, Paul B.
    Schneider, Amy
    Chavez, Carlos
    Lu, Hong
    Pak, Min
    Blake-Haskins, Andy
    Vasselll, Jim
    Ibrahim, Ramy A.
    Shalabi, Aiman M.
    Roskos, Lorin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [25] A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors
    Yasutsuna Sasaki
    Keisuke Miwa
    Keishi Yamashita
    Yu Sunakawa
    Ken Shimada
    Hiroo Ishida
    Kosei Hasegawa
    Keiichi Fujiwara
    Makoto Kodaira
    Yasuhiro Fujiwara
    Masayuki Namiki
    Minami Matsuda
    Yutaka Takeuchi
    Noriyuki Katsumata
    Investigational New Drugs, 2015, 33 : 332 - 340
  • [26] Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors
    Toshio Shimizu
    Takashi Seto
    Fumihiko Hirai
    Mitsuhiro Takenoyama
    Kaname Nosaki
    Junji Tsurutani
    Hiroyasu Kaneda
    Tsutomu Iwasa
    Hisato Kawakami
    Kazuo Noguchi
    Takashi Shimamoto
    Kazuhiko Nakagawa
    Investigational New Drugs, 2016, 34 : 347 - 354
  • [27] Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors
    Shimizu, Toshio
    Seto, Takashi
    Hirai, Fumihiko
    Takenoyama, Mitsuhiro
    Nosaki, Kaname
    Tsurutani, Junji
    Kaneda, Hiroyasu
    Iwasa, Tsutomu
    Kawakami, Hisato
    Noguchi, Kazuo
    Shimamoto, Takashi
    Nakagawa, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2016, 34 (03) : 347 - 354
  • [28] A first-in-human phase dose-escalation study of YH002, a recombinant humanized agonistic anti-OX40 IgG1 monoclonal antibody, in patients with advanced solid tumors.
    Ganju, Vinod
    Cooper, Adam
    Wilkinson, Kate
    Park, John J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] Phase Ia study of a humanized anti-PD-1 monoclonal antibody (JS']JS001) in Chinese patients with refractory solid tumors
    Wang, F-H.
    Ren, C.
    Zhang, Y.
    Yao, S.
    Feng, H.
    Wu, H.
    Song, H-F.
    Zhang, R.
    Wei, X-L.
    Xia, X-J.
    Zhao, Q.
    Yun, J-P.
    Zou, B-Y.
    Qiu, M.
    Wang, Z-Q.
    Li, Y-H.
    Xu, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [30] A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors
    Weekes, Colin D.
    Beeram, Muralidhar
    Tolcher, Anthony W.
    Papadopoulos, Kyriakos P.
    Gore, Lia
    Hegde, Priti
    Xin, Yan
    Yu, Ron
    Shih, L. Mason
    Xiang, Hong
    Brachmann, Rainer K.
    Patnaik, Amita
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 653 - 660
12345